Adelaide University researchers found that salcaprozate sodium (SNAC), an absorption enhancer in tablet forms of Wegovy and Ozempic, was associated with changes in gut bacteria, inflammatory markers, and brain-related proteins in an animal study over 21 days. While the study does not demonstrate harm in humans, researchers call for further investigation into long-term effects as oral versions of these weight-loss medications gain wider use.
1 comment
Adelaide University researchers found that salcaprozate sodium (SNAC), an absorption enhancer in tablet forms of Wegovy and Ozempic, was associated with changes in gut bacteria, inflammatory markers, and brain-related proteins in an animal study over 21 days. While the study does not demonstrate harm in humans, researchers call for further investigation into long-term effects as oral versions of these weight-loss medications gain wider use.